SARS-CoV-话题@MedSci

#SARS-CoV#

221篇内容 | 3640人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1937965, encodeId=1fa4193e96557, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, objectTitle=Lancet：**波新冠肺炎疫情中，美国SARS-CoV-2抗体阳性率研究, objectType=article, longId=202497, objectId=165220249eb4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=165220249eb4, replyNumber=0, likeNumber=55, createdTime=2021-03-23, rootId=0, userName=hukaixun, userId=6ab940, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=165220249eb4, moduleTitle=Lancet：**波新冠肺炎疫情中，美国SARS-CoV-2抗体阳性率研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=165220249eb4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1937986, encodeId=b703193e986ec, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, objectTitle=葡萄柚籽提取物和木糖醇Xlear可杀死和/或灭活SARS-CoV-2 可有效抵御新的变异病毒, objectType=article, longId=206359, objectId=e72720635909, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e72720635909, replyNumber=0, likeNumber=69, createdTime=2021-07-19, rootId=0, userName=hukaixun, userId=6ab940, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e72720635909, moduleTitle=葡萄柚籽提取物和木糖醇Xlear可杀死和/或灭活SARS-CoV-2 可有效抵御新的变异病毒, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e72720635909)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1937950, encodeId=6bb9193e95056, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, objectTitle=Ampligen或可预防COVID-19，体外模型证明Ampligen将SARS-CoV-2病毒载量降低90％, objectType=article, longId=200064, objectId=d39420006480, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d39420006480, replyNumber=0, likeNumber=91, createdTime=2021-07-16, rootId=0, userName=hukaixun, userId=6ab940, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d39420006480, moduleTitle=Ampligen或可预防COVID-19，体外模型证明Ampligen将SARS-CoV-2病毒载量降低90％, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d39420006480)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1937937, encodeId=0455193e93727, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, objectTitle=Clinica Chimica Acta：血清SARS-CoV-2检测诊断性能和阈值, objectType=article, longId=197777, objectId=1cff19e77762, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1cff19e77762, replyNumber=0, likeNumber=62, createdTime=2020-11-28, rootId=0, userName=hukaixun, userId=6ab940, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1cff19e77762, moduleTitle=Clinica Chimica Acta：血清SARS-CoV-2检测诊断性能和阈值, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1cff19e77762)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1938010, encodeId=8fe619380103e, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, objectTitle=BMJ：是否应该为儿童接种抗SARS-CoV-2疫苗, objectType=article, longId=211382, objectId=4229211382c4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4229211382c4, replyNumber=0, likeNumber=63, createdTime=2021-10-05, rootId=0, userName=hukaixun, userId=6ab940, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4229211382c4, moduleTitle=BMJ：是否应该为儿童接种抗SARS-CoV-2疫苗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4229211382c4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1937945, encodeId=0339193e945b9, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, objectTitle=Clinica Chimica Acta：血清和血浆样品中商用抗SARS-CoV-2免疫检测的测试性能比较, objectType=article, longId=199083, objectId=23b1199083fb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=23b1199083fb, replyNumber=0, likeNumber=51, createdTime=2021-06-14, rootId=0, userName=hukaixun, userId=6ab940, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=23b1199083fb, moduleTitle=Clinica Chimica Acta：血清和血浆样品中商用抗SARS-CoV-2免疫检测的测试性能比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=23b1199083fb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1937972, encodeId=66b7193e97231, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, objectTitle=Nat Med：中国万州是如何有效控制SARS-CoV-2病毒传播？, objectType=article, longId=203997, objectId=bbca20399e5c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bbca20399e5c, replyNumber=0, likeNumber=70, createdTime=2021-08-31, rootId=0, userName=hukaixun, userId=6ab940, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bbca20399e5c, moduleTitle=Nat Med：中国万州是如何有效控制SARS-CoV-2病毒传播？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bbca20399e5c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1937970, encodeId=3d72193e970fd, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, objectTitle=JCC: 生物制剂疗法对于IBD患者患有SARS-CoV2阳性的概率的影响, objectType=article, longId=203627, objectId=e64f20362e03, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e64f20362e03, replyNumber=0, likeNumber=63, createdTime=2021-05-14, rootId=0, userName=hukaixun, userId=6ab940, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e64f20362e03, moduleTitle=JCC: 生物制剂疗法对于IBD患者患有SARS-CoV2阳性的概率的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e64f20362e03)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1938005, encodeId=72b0193800551, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, objectTitle=LANCET：彻底消除SARS-CoV-2才能为健康、经济和公民自由创造更佳结果, objectType=article, longId=210666, objectId=8b8b21066689, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8b8b21066689, replyNumber=0, likeNumber=53, createdTime=2022-01-18, rootId=0, userName=hukaixun, userId=6ab940, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8b8b21066689, moduleTitle=LANCET：彻底消除SARS-CoV-2才能为健康、经济和公民自由创造更佳结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8b8b21066689)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1937973, encodeId=7d9f193e97385, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, objectTitle=Pharmacol Res：瑞德西韦治疗住院SARS-CoV-2肺炎患者的疗效, objectType=article, longId=204108, objectId=e43220410849, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e43220410849, replyNumber=0, likeNumber=67, createdTime=2021-02-07, rootId=0, userName=hukaixun, userId=6ab940, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e43220410849, moduleTitle=Pharmacol Res：瑞德西韦治疗住院SARS-CoV-2肺炎患者的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e43220410849)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1937989, encodeId=0cf4193e989f2, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, objectTitle=Gut：伴有SARS-CoV-2感染的急性胰腺炎患者严重程度和30天死亡率增加, objectType=article, longId=207022, objectId=9b0520e02287, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9b0520e02287, replyNumber=0, likeNumber=83, createdTime=2022-01-06, rootId=0, userName=hukaixun, userId=6ab940, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9b0520e02287, moduleTitle=Gut：伴有SARS-CoV-2感染的急性胰腺炎患者严重程度和30天死亡率增加, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9b0520e02287)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1937935, encodeId=b81c193e93548, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, objectTitle=Science：强效中和SARS-CoV-2的人类抗体，都具有这种“优秀”基因, objectType=article, longId=197568, objectId=21cc19e5683c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=21cc19e5683c, replyNumber=0, likeNumber=65, createdTime=2020-09-05, rootId=0, userName=hukaixun, userId=6ab940, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=21cc19e5683c, moduleTitle=Science：强效中和SARS-CoV-2的人类抗体，都具有这种“优秀”基因, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=21cc19e5683c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1937933, encodeId=6ac5193e933c4, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, objectTitle=CELL：从新冠患者中分离出强效的近种系SARS-CoV-2中和抗体, objectType=article, longId=197337, objectId=45e619e33750, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=45e619e33750, replyNumber=0, likeNumber=53, createdTime=2021-03-10, rootId=0, userName=hukaixun, userId=6ab940, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=45e619e33750, moduleTitle=CELL：从新冠患者中分离出强效的近种系SARS-CoV-2中和抗体, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=45e619e33750)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1937941, encodeId=4d31193e94171, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, objectTitle=Science：我国科学家从结构上揭示一种强效的治疗性抗体中和SARS-CoV-2和SARS-CoV机制, objectType=article, longId=198142, objectId=bb07198142be, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bb07198142be, replyNumber=0, likeNumber=69, createdTime=2021-02-15, rootId=0, userName=hukaixun, userId=6ab940, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bb07198142be, moduleTitle=Science：我国科学家从结构上揭示一种强效的治疗性抗体中和SARS-CoV-2和SARS-CoV机制, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bb07198142be)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1937939, encodeId=930d193e93974, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, objectTitle=Cell Research:钟南山等团队，中国医院就诊人员的SARS-CoV-2血清学研究进展, objectType=article, longId=197953, objectId=5a0019e953fb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5a0019e953fb, replyNumber=0, likeNumber=86, createdTime=2021-02-15, rootId=0, userName=hukaixun, userId=6ab940, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5a0019e953fb, moduleTitle=Cell Research:钟南山等团队，中国医院就诊人员的SARS-CoV-2血清学研究进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5a0019e953fb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1937940, encodeId=afcb193e94021, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, objectTitle=NATURE：大规模筛选，老药新用对抗SARS-CoV-2, objectType=article, longId=198020, objectId=9647198020b9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9647198020b9, replyNumber=0, likeNumber=69, createdTime=2021-07-08, rootId=0, userName=hukaixun, userId=6ab940, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9647198020b9, moduleTitle=NATURE：大规模筛选，老药新用对抗SARS-CoV-2, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9647198020b9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1937916, encodeId=2c73193e9165f, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, objectTitle=CELL：中国广东省SARS-CoV-2的基因组流行病学研究 , objectType=article, longId=193356, objectId=8e6e1933568b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8e6e1933568b, replyNumber=0, likeNumber=56, createdTime=2021-02-18, rootId=0, userName=hukaixun, userId=6ab940, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8e6e1933568b, moduleTitle=CELL：中国广东省SARS-CoV-2的基因组流行病学研究 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8e6e1933568b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1937912, encodeId=c55e193e9128c, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, objectTitle=Mol Biol Evol：新研究称流浪狗或为SARS-CoV-2中间宿主，剑桥专家认为“不靠谱”, objectType=article, longId=192410, objectId=301e192410c8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=301e192410c8, replyNumber=0, likeNumber=50, createdTime=2020-09-28, rootId=0, userName=hukaixun, userId=6ab940, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=301e192410c8, moduleTitle=Mol Biol Evol：新研究称流浪狗或为SARS-CoV-2中间宿主，剑桥专家认为“不靠谱”, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=301e192410c8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1937964, encodeId=d640193e96495, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, objectTitle=Nature：SARS-CoV-2多个中和抗体结构被解析，为治疗提供依据, objectType=article, longId=202032, objectId=069a20203240, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=069a20203240, replyNumber=0, likeNumber=73, createdTime=2021-09-23, rootId=0, userName=hukaixun, userId=6ab940, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=069a20203240, moduleTitle=Nature：SARS-CoV-2多个中和抗体结构被解析，为治疗提供依据, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=069a20203240)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1938000, encodeId=c8131938000f7, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, objectTitle=NEJM:加州医护人员接种SARS-CoV-2疫苗后感染情况调查, objectType=article, longId=209007, objectId=42fe20900ef2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=42fe20900ef2, replyNumber=0, likeNumber=83, createdTime=2021-08-30, rootId=0, userName=hukaixun, userId=6ab940, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=42fe20900ef2, moduleTitle=NEJM:加州医护人员接种SARS-CoV-2疫苗后感染情况调查, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=42fe20900ef2)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

SARS-CoV

2020-05-29

hukaixun (审核中...)

前往app查看评论内容

#SARS-CoV#

Lancet：**波新冠肺炎疫情中，美国SARS-CoV-2抗体阳性率研究

2021-03-23

hukaixun (审核中...)

前往app查看评论内容

#SARS-CoV#

葡萄柚籽提取物和木糖醇Xlear可杀死和/或灭活SARS-CoV-2 可有效抵御新的变异病毒

2021-07-19

hukaixun (审核中...)

前往app查看评论内容

#SARS-CoV#

Ampligen或可预防COVID-19，体外模型证明Ampligen将SARS-CoV-2病毒载量降低90％

2021-07-16

hukaixun (审核中...)

前往app查看评论内容

#SARS-CoV#

Clinica Chimica Acta：血清SARS-CoV-2检测诊断性能和阈值

2020-11-28

hukaixun (审核中...)

前往app查看评论内容

#SARS-CoV#

BMJ：是否应该为儿童接种抗SARS-CoV-2疫苗

2021-10-05

hukaixun (审核中...)

前往app查看评论内容

#SARS-CoV#

Clinica Chimica Acta：血清和血浆样品中商用抗SARS-CoV-2免疫检测的测试性能比较

2021-06-14

hukaixun (审核中...)

前往app查看评论内容

#SARS-CoV#

Nat Med：中国万州是如何有效控制SARS-CoV-2病毒传播？

2021-08-31

hukaixun (审核中...)

前往app查看评论内容

#SARS-CoV#

JCC: 生物制剂疗法对于IBD患者患有SARS-CoV2阳性的概率的影响

2021-05-14

hukaixun (审核中...)

前往app查看评论内容

#SARS-CoV#

LANCET：彻底消除SARS-CoV-2才能为健康、经济和公民自由创造更佳结果

2022-01-18

hukaixun (审核中...)

前往app查看评论内容

#SARS-CoV#

Pharmacol Res：瑞德西韦治疗住院SARS-CoV-2肺炎患者的疗效

2021-02-07

hukaixun (审核中...)

前往app查看评论内容

#SARS-CoV#

Gut：伴有SARS-CoV-2感染的急性胰腺炎患者严重程度和30天死亡率增加

2022-01-06

hukaixun (审核中...)

前往app查看评论内容

#SARS-CoV#

Science：强效中和SARS-CoV-2的人类抗体，都具有这种“优秀”基因

2020-09-05

hukaixun (审核中...)

前往app查看评论内容

#SARS-CoV#

CELL：从新冠患者中分离出强效的近种系SARS-CoV-2中和抗体

2021-03-10

hukaixun (审核中...)

前往app查看评论内容

#SARS-CoV#

Science：我国科学家从结构上揭示一种强效的治疗性抗体中和SARS-CoV-2和SARS-CoV机制

2021-02-15

hukaixun (审核中...)

前往app查看评论内容

#SARS-CoV#

Cell Research:钟南山等团队，中国医院就诊人员的SARS-CoV-2血清学研究进展

2021-02-15

hukaixun (审核中...)

前往app查看评论内容

#SARS-CoV#

NATURE：大规模筛选，老药新用对抗SARS-CoV-2

2021-07-08

hukaixun (审核中...)

前往app查看评论内容

#SARS-CoV#

CELL：中国广东省SARS-CoV-2的基因组流行病学研究

2021-02-18

hukaixun (审核中...)

前往app查看评论内容

#SARS-CoV#

Mol Biol Evol：新研究称流浪狗或为SARS-CoV-2中间宿主，剑桥专家认为“不靠谱”

2020-09-28

hukaixun (审核中...)

前往app查看评论内容

#SARS-CoV#

Nature：SARS-CoV-2多个中和抗体结构被解析，为治疗提供依据

2021-09-23

hukaixun (审核中...)

前往app查看评论内容

#SARS-CoV#

NEJM:加州医护人员接种SARS-CoV-2疫苗后感染情况调查

2021-08-30

科室
- - 订阅+
  - 更多科室
工具
服务